Rui Wu

No ORCID on file · 4 papers in corpus · active 2009-2025

Study types

  • article 4

Condition tags

  • endometriosis 2
  • adenomyosis 2
article 2025
Fertility and sterility ·doi:10.1016/j.fertnstert.2025.04.037

OBJECTIVE: To assess the effects of relugolix combination therapy in women with uterine fibroids (UFs) and concomitant ultrasound-diagnosed adenomyosis. DESIGN: This post hoc analysis used pooled data from completers of the pivotal LIBERTY …

article 2023
·doi:10.1097/01.aog.0000929840.36823.a1

INTRODUCTION: Adenomyosis and uterine fibroids (UFs) may coexist in women with heavy menstrual bleeding (HMB). Relugolix combination therapy (Relugolix-CT: relugolix 40 mg, estradiol 1 mg, norethindrone acetate 0.5 mg) is approved in the Un…

article 2015
PloS one ·doi:10.1371/journal.pone.0145290

Aquaporin 5 (AQP5) participates in the migration of endometrial cells. Elucidation of the molecular mechanisms associated with AQP5-mediated, migration of endometrial cells may contribute to a better understanding of endometriosis. Our obje…

article 2009
·doi:10.1016/s0020-7292(09)60795-5